CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,410
- in 2 filings
Net −$5,410. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-17 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Sale | −2,230 | $1.93 | $4K | 294,379 |
| 2026-03-19 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Sale | −12,311 | $2.17 | $27K | 293,609 |
| 2026-02-17 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −2,201 | $2.27 | $5K | 305,920 |
| 2026-01-26 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award · Stock option (right to buy) | +912,000 | 912,000 | ||
| 2025-10-14 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +597,500 | 597,500 | ||
| 2025-09-17 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Purchase | +71,163 | $1.08 | $77K | 305,121 |
| 2025-09-16 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Purchase | +21,070 | $1.07 | $22K | 233,958 |
| 2025-08-15 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Sale | −2,382 | $0.64 | $2K | 212,888 |
| 2025-04-11 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2025-03-14 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award | +42,000 | 212,270 | ||
| 2025-02-19 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Sale | −2,159 | $1.15 | $2K | 170,270 |
| 2025-01-21 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +478,000 | 478,000 | ||
| 2024-12-02 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-08-14 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Shares withheld for taxes | −2,191 | $2.58 | $6K | 169,429 |
| 2024-03-14 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Purchase | +4,400 | $11.31 | $50K | 171,620 |
| 2024-02-14 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award | +60,000 | 167,220 | ||
| 2024-02-14 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option | +190,000 | 190,000 | ||
| 2023-09-08 | Lettmann Jason Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +1,200,000 | 1,200,000 | ||
| 2023-06-20 | Lettmann Jason Director | Grant or award · Stock option (right to buy) | +20,200 | 20,200 | ||
| 2022-06-15 | Lettmann Jason Director | Grant or award · Common Stock (right to buy) | +12,004 | 12,004 |
Page 1 of 4 · 71 trades